Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김완규 | - |
| dc.date.accessioned | 2026-11-17T16:30:03Z | - |
| dc.date.available | 2026-11-17T16:30:03Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.issn | 1201-9712 | - |
| dc.identifier.issn | 1878-3511 | - |
| dc.identifier.other | OAK-40559 | - |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/276905 | - |
| dc.description.abstract | Objectives: Few large-scale population-based studies have examined the association between COVID-19 and respiratory aspergillosis. Using nationwide data, we investigated whether SARS-CoV-2 infection increases respiratory aspergillosis incidence and whether COVID-19-associated aspergillosis affects COVID19 severity. We also analyzed public COVID-19 transcriptomic datasets to assess effects on airway structural and immune cells. Design or Methods : From a nationwide cohort of 8.5 million clinical registries, we included over 550,0 0 0 patients diagnosed with COVID-19 between October 8, 2020, and December 31, 2021, and matched controls. Outcomes were respiratory aspergillosis incidence, including invasive and noninvasive forms, and its association with COVID-19 severity. Results: COVID-19 was associated with increased subsequent respiratory aspergillosis. Diabetes, COPD, and other comorbidities further increased fungal infection incidence among COVID-19 patients. Both invasive and noninvasive aspergillosis were associated with greater COVID-19 severity. Systemic corticosteroid use markedly increased severity and mortality in both forms. Antifungal-related genes and pathways, including CCR6, CXCL9, and CX3CR1, were consistently downregulated after SARS-CoV-2 infection and/or corticosteroid treatment. Conclusion: COVID-19 was associated with increased respiratory aspergillosis incidence, and respiratory aspergillosis was associated with worse COVID-19 outcomes regardless of invasiveness. Further studies should evaluate whether antifungal treatment improves COVID-19 outcomes. on behalf of International Society for Infectious ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) | - |
| dc.language | English | - |
| dc.publisher | ELSEVIER SCI LTD | - |
| dc.subject | COVID-19 | - |
| dc.subject | Respiratory aspergillosis | - |
| dc.subject | Transcriptome | - |
| dc.title | Noninvasive aspergillosis following COVID-19 exacerbates the severity of SARS-CoV-2 infection | - |
| dc.type | Article | - |
| dc.relation.volume | 172 | - |
| dc.relation.index | SCIE | - |
| dc.relation.index | SCOPUS | - |
| dc.relation.journaltitle | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | - |
| dc.identifier.doi | 10.1016/j.ijid.2026.109095 | - |
| dc.identifier.wosid | WOS:001888332200001 | - |
| dc.identifier.scopusid | 2-s2.0-105051572753 | - |
| dc.author.google | Kim, Jong Seung | - |
| dc.author.google | Park, Jun Hyung | - |
| dc.author.google | Kim, Juhyun | - |
| dc.author.google | Lee, Yong Chul | - |
| dc.author.google | Yang, Ji Won | - |
| dc.author.google | You, Yeon Seok | - |
| dc.author.google | Kim, Gwangsu | - |
| dc.author.google | Kim, Wankyu | - |
| dc.author.google | Jeong, Jae Seok | - |
| dc.contributor.scopusid | 김완규(25627654100) | - |
| dc.date.modifydate | 20261117125951 | - |